simendan has been researched along with Pulmonary Arterial Hypertension in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behera, SK; Chowdhury, SR; Das, M; Nag, P; Narayan, P | 1 |
1 trial(s) available for simendan and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.
Topics: Cardiotonic Agents; Child; Heart Septal Defects, Ventricular; Heart Ventricles; Humans; Hydrazones; Milrinone; Prospective Studies; Pulmonary Arterial Hypertension; Pyridazines; Simendan | 2023 |